cGxP.wire https://validator.w3.org/feed/docs/rss2.html AbbVie Secures EU Approval for AQUIPTA as Acute Migraine Treatment Evogene Reports Positive Phase 1 Data for BMC128 in Cancer Resmed Completes Noctrix Health Acquisition to Expand Sleep Care Alamar Launches NULISA Kit for Home-Based Proteomics Lupin and Natco Win U.S. FDA Approval for Eribulin Injection Johnson & Johnson’s Nipocalimab Shows Strong SLE Results IDEAYA and Roche Advance Targeted Therapy for PDAC Antengene Presents First ATG-207 Autoimmune Disease Data at EULAR 2026 Stelexis BioSciences Reports Breakthrough Phase 1 Eganelisib Results in AML and MDS AvenCell Therapeutics to Present First Phase 1 Results for Switchable Allogeneic CAR-T Therapy in AML Servier Acquires Edgewise Muscular Dystrophy Business for $2.65B Medtronic Expands Hugo Robotic Surgery System with New FDA Filings Ascidian and Lilly Sign $1.9B Kidney Disease RNA Deal Celcuity’s Gedatolisib Doubles Progression-Free Survival in Phase 3 Breast Cancer Trial SCIEX Launches AI-Powered Novus V55 Mass Spectrometry System Fulcrum Ends Pociredir Program After FDA Concerns Over Sickle Cell Therapy Sofinnova Partners Leads €13M Investment in AI Biology Startup Ingenix Galmed and Tissue Dynamics Uncover Novel Pathway in Cardiac Fibrosis Telix and United Imaging Partner to Advance AI-Driven Theranostics DHCG and Altruist Partner to Advance Biologics in China Abivax’s Obefazimod Delivers Landmark Phase 3 Success in Ulcerative Colitis ImmunityBio Highlights ANKTIVA Data in Lung and Bladder Cancer at ASCO 2026 SCIEX Expands ZenoTOF Platform with AI and Omics Research Innovations Alife Health Receives FDA Clearance for AI-Powered Embryo Selection Technology Telix Presents Encouraging Phase 3 Results for TLX591-Tx at ASCO 2026 Ansun Biopharma Advances Phase 3 DAS181 Trial Following Positive DMC Review Convergent’s CONV01-α Shows Promising Activity in Post-Lu-PSMA Prostate Cancer Phase 2 Study Cirius Therapeutics Highlights CIR-0602K as Promising New Therapy for Type 2 Diabetes Karyopharm Highlights Phase 3 SENTRY Trial Progress in Myelofibrosis Made Scientific Selected for Columbia’s NOVAKnee Program Ono’s ONO-4578 Improves Progression-Free Survival in Gastric Cancer Phase 2 Study Endeavor Health Unveils Advanced Genetic Test for Heart Disease Roche’s Giredestrant NDA Accepted by FDA for Early Breast Cancer FDA Accepts Genentech NDA for Giredestrant in Early Breast Cancer Paradigm Health Advances Oncology Research with SPIRE-Powered ASCO Study Greywolf Reports Durable Responses with First-in-Class ERAP1 Inhibitor Iterion Reports First Clinical Validation of Tegavivint in Advanced HCC Hummingbird Diagnostics Unveils Lung Cancer Liquid Biopsy Biomarker Mechanism UCB and Biogen Report Positive Phase 3 Lupus Results for Dapirolizumab Pegol in The Lancet Rallybio and Avenzo Merge to Advance Oncology Pipeline with $215M Financing Vertex FDA Accepts Povetacicept BLA for IgA Nephropathy Agilent and Sound Analytics Advance Drug Metabolism LC/MS Avenzo Reports Promising Phase 1 Data for AVZO-021 in HR+ Breast Cancer SystImmune’s BL-M14D1 Shows Strong Activity in SCLC Philips Gains FDA Clearance for AI Ultrasound Upgrade Citius Oncology Reports Promising LYMPHIR Cancer Data Protagonist to Showcase Phase 3 VERIFY and Long-Term Rusfertide Data at EHA 2026 Servier’s Emi-Le Shows Promise in Rare ACC Cancer Trial IDEAYA and Servier Report Breakthrough mUM Phase 3 Data AstraZeneca’s Camizestrant Extends Survival in ESR1-Mutant Breast Cancer